Peter Lynch fit · Growth at a reasonable price (GARP)
Is Collegium Pharmaceutical, Inc. Common Stock (COLL) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
46/100
DSignaux mixtes
4/6 critères validés
Les critères de Peter Lynch, appliqués à COLL
PEG ≤ 1.0
clé—
EPS CAGR ≥ 15%
clé20.4%
Revenue CAGR ≥ 10%
7.6%
Net margin > 0
7.7%
Comment COLL se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$1.49B
PER (TTM)
21.8x
ROIC (TTM)
9.78%
Marge brute
57.22%
Questions fréquentes
What is COLL's Peter Lynch fit score?
COLL scores 46/100 on our Peter Lynch fit engine — grade D. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own COLL?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends COLL.
How often is this score updated?
COLL's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Peter Lynch possède ou recommande COLL personnellement.